High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

BACKGROUND: Interferon-alpha monotherapy is effective in less than one-third patients with chronic hepatitis C. The dose-effect, tolerability and durability of interferon-alpha treatment and its long-term effect on the prevention of cirrhosis and hepatocellular carcinoma in naïve Taiwanese patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ming-Lung, Dai, Chia-Yen, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Tsai, Jung-Fa, Chang, Wen-Yu, Chuang, Wan-Long
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090579/
https://www.ncbi.nlm.nih.gov/pubmed/15823212
http://dx.doi.org/10.1186/1471-2334-5-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090579/
https://www.ncbi.nlm.nih.gov/pubmed/15823212
http://dx.doi.org/10.1186/1471-2334-5-27

Ejemplares similares